Print

Print


TASMAR UPDATE                                   04 May 1999
Besides the three cases of tolcapone (Tasmar)-associated fatal
liver failures last year among the more than 60,000 users, that
prompted the requirement for periodic blood testing, I've found
four reports of deaths from other or unknown causes among Tasmar
users, with only slight hints of possible liver damage. As of
February 1999, I have seen no case where monitoring has not
provided effective warning of potential liver failure. Cheers,
Joe
--
J. R. Bruman   (818) 789-3694
3527 Cody Road
Sherman Oaks, CA 91403-5013